RTW Investments’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-6,768,514
| Closed | -$398M | – | 79 |
|
|
2023
Q4 | $398M | Hold |
6,768,514
| – | – | 6.21% | 3 |
|
|
2023
Q3 | $295M | Buy |
6,768,514
+2,295,529
| +51% | +$82M | 6.22% | 5 |
|
|
2023
Q2 | $162M | Buy |
4,472,985
+829,871
| +23% | +$34.2M | 3.08% | 13 |
|
|
2023
Q1 | $135M | Hold |
3,643,114
| – | – | 2.82% | 15 |
|
|
2022
Q4 | $165M | Buy |
3,643,114
+1,760,451
| +94% | +$114M | 3.37% | 11 |
|
|
2022
Q3 | $131M | Hold |
1,882,663
| – | – | 3.03% | 10 |
|
|
2022
Q2 | $126M | Buy |
1,882,663
+321,166
| +21% | +$20.4M | 3.27% | 9 |
|
|
2022
Q1 | $128M | Hold |
1,561,497
| – | – | 2.66% | 10 |
|
|
2021
Q4 | $229M | Buy |
1,561,497
+68,965
| +5% | +$10.7M | 3.34% | 6 |
|
|
2021
Q3 | $264M | Buy |
1,492,532
+35,000
| +2% | +$5.63M | 3.98% | 4 |
|
|
2021
Q2 | $235M | Buy |
1,457,532
+124,300
| +9% | +$20M | 3.55% | 6 |
|
|
2021
Q1 | $228M | Buy |
1,333,232
+278,868
| +26% | +$55.2M | 3.57% | 6 |
|
|
2020
Q4 | $232M | Sell |
1,054,364
-41,641
| -4% | -$9M | 3.89% | 4 |
|
|
2020
Q3 | $182M | Buy |
1,096,005
+8,279
| +0.8% | +$1.13M | 4.38% | 5 |
|
|
2020
Q2 | $124M | Buy |
1,087,726
+102,560
| +10% | +$9.95M | 3.49% | 8 |
|
|
2020
Q1 | $75.7M | Buy |
985,166
+339,739
| +53% | +$30.5M | 3.26% | 7 |
|
|
2019
Q4 | $83.2M | Buy |
645,427
+52,651
| +9% | +$5.08M | 3.14% | 9 |
|
|
2019
Q3 | $46.2M | Buy |
592,776
+337,506
| +132% | +$31.7M | 2.75% | 12 |
|
|
2019
Q2 | $26.3M | Sell |
255,270
-56,823
| -18% | -$4.42M | 1.4% | 22 |
|
|
2019
Q1 | $22.9M | Buy |
312,093
+273,328
| +705% | +$18.6M | 1.56% | 22 |
|
|
2018
Q4 | $1.64M | Buy |
+38,765
| New | +$1.54M | 0.15% | 43 |
|
|
2017
Q1 | – | Sell |
-129,697
| Closed | -$616K | – | 33 |
|
|
2016
Q4 | $616K | Buy |
129,697
+568
| +0.4% | +$3.09K | 0.23% | 25 |
|
|
2016
Q3 | $854K | Sell |
129,129
-1,923
| -1% | -$10.2K | 0.26% | 29 |
|
|
2016
Q2 | $716K | Sell |
131,052
-297,405
| -69% | -$4.74M | 0.24% | 31 |
|
|
2016
Q1 | $9.17M | Buy |
428,457
+43,001
| +11% | +$962K | 3.33% | 12 |
|
|
2015
Q4 | $12.2M | Sell |
385,456
-96,613
| -20% | -$3.41M | 3.96% | 8 |
|
|
2015
Q3 | $16.6M | Buy |
+482,069
| New | +$14.6M | 5.16% | 7 |
|
Other funds holding MRTX
RTW Investments's MRTX Position: Q1 2024 in Review
RTW Investments sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 6,768,514 shares — an estimated $398M sold.
RTW Investments first reported a position in MRTX in Q3 2015 and held it in 27 quarters. The position peaked at $398M in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.
- RTW Investments reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- RTW Investments sold 6,768,514 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $398M.
- RTW Investments first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2015 and held it in 27 quarters.
- RTW Investments's Mirati Therapeutics, Inc. Common Stock position peaked at $398M in Q4 2023.
- 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.
Based on RTW Investments's 13F filing for Q1 2024, filed 15 May 2024.